XLON
AVG
Market cap284mUSD
Jul 09, Last price
630.00GBP
1D
0.00%
1Q
14.55%
Jan 2017
226.42%
IPO
767.92%
Name
Avingtrans PLC
Chart & Performance
P/E
32.30
P/S
1.35
EPS
0.20
Div Yield, %
0.78%
Shrs. gr., 5y
1.11%
Rev. gr., 5y
5.60%
Revenues
156m
+14.49%
Net income
7m
+79.08%
CFO
12m
+770.39%
Dividend
May 28, 20262 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Avingtrans plc operates as a global provider of specialized engineered products, integrated systems, and technical services, catering to the energy, healthcare, and infrastructure sectors. The company's operations are structured into three distinct divisions: Energy-EPM, Energy-PSRE, and Medical-MII. Avingtrans demonstrates expertise in the design, production, integration, and maintenance of various robust equipment, including electric motors and pumps, steam turbines, gas compressors, heavy-duty pressure vessels, blast-resistant doors, specialized containers, and modular skidded systems. Furthermore, the company develops and manufactures advanced equipment for the scientific and medical communities. This includes components for diagnostic medical devices, high-specification pressure and vacuum vessels, and composite materials tailored for research institutions. They also supply superconducting magnets and helium-free cryogenic systems, which are essential for applications such as Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR). Founded in 1985, Avingtrans plc maintains its headquarters in Chatteris, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑05 | 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||